BA
AMPE

BlackRock Advisors’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

BlackRock Advisors’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$19K Hold
70
– – ﹤0.01% 3471
2016
Q3 		$16K Sell
70
-3
-4% -$841 ﹤0.01% 3497
2016
Q2 		$28K Buy
73
+43
+143% +$47K ﹤0.01% 3366
2016
Q1 		$20K Hold
30
– – ﹤0.01% 3431
2015
Q4 		$31K Hold
30
– – ﹤0.01% 3360
2015
Q3 		$26K Hold
30
– – ﹤0.01% 3451
2015
Q2 		$21K Sell
30
-65
-68% -$69.3K ﹤0.01% 3503
2015
Q1 		$215K Buy
95
+12
+14% +$20.5K ﹤0.01% 2633
2014
Q4 		$85K Sell
83
-5
-6% -$5.34K ﹤0.01% 3121
2014
Q3 		$93K Hold
88
– – ﹤0.01% 3044
2014
Q2 		$219K Sell
88
-9
-9% -$18.4K ﹤0.01% 2578
2014
Q1 		$185K Buy
97
+26
+37% +$61.5K ﹤0.01% 2684
2013
Q4 		$152K Buy
71
+10
+16% +$23.6K ﹤0.01% 2827
2013
Q3 		$138K Buy
61
+5
+9% +$9.67K ﹤0.01% 2762
2013
Q2 		$98K Buy
+56
New +$88.9K ﹤0.01% 2918

Other funds holding AMPE

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NFG
Noven Financial Group Denver, Colorado $123M AUM 5.23% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

BlackRock Advisors's AMPE Position: Q4 2016 in Review

BlackRock Advisors held its Ampio Pharmaceuticals Inc. (AMPE) position steady in Q4 2016 at 70 shares worth $19K. The position accounts for ﹤0.01% of the portfolio, ranked #3471.

BlackRock Advisors first reported a position in AMPE in Q2 2013 and has held it in 15 quarters since. The position peaked at $219K in Q2 2014. 71 funds tracked by Wall St. Rank hold AMPE as of Q4 2016.

  • BlackRock Advisors held 70 shares of Ampio Pharmaceuticals Inc. worth $19K as of Q4 2016.
  • BlackRock Advisors left its Ampio Pharmaceuticals Inc. share count unchanged in Q4 2016.
  • Ampio Pharmaceuticals Inc. made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3471 holding.
  • BlackRock Advisors first reported a position in Ampio Pharmaceuticals Inc. in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Advisors's Ampio Pharmaceuticals Inc. position peaked at $219K in Q2 2014.
  • 71 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.